Pharmafile Logo
Pharmafocus logo
Advanced Search

Private firms account for a third of NHS contracts

December 10, 2014
Medical Communications, Sales and Marketing Budget, Cameron, Hunt, NHS, Osborne, autumn, election, privatisation

A large percentage of NHS contracts in England have been awarded to private sector providers since 2013, according to data …

News
NHS image

Labour to extend cancer drugs funding if elected

December 10, 2014
Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …

News
Joe Jimenez image

EFPIA gives president role to Novartis chief executive

December 10, 2014
Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …

News
michel-de-rosen

Pharnext adds industry veteran to board

December 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …

Appointment
AZ image

AstraZeneca constipation drug gets EU nod

December 9, 2014
Sales and Marketing AstraZeneca, KODIAC, NKTR-118, PAMORA, moventig, naloxegol

AstraZeneca’s opioid-induced constipation drug Moventig has been approved by the European Commission. The first once-daily PAMORA tablet to be given …

News
Janssen image

NICE U-turn over Janssen arthritis drug

December 9, 2014
Sales and Marketing Janssen, NHS, NICE, Stelara, arthritis, ustekinumab

NICE has reversed its decision on Janssen’s Stelara and is now recommending the active psoriatic arthritis drug. The pricing watchdog …

News
bayer_healthcare

Mixed results for new leukaemia drugs

December 9, 2014
Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …

News
Sandoz image

Novartis biosimilar rivals Amgen offering

December 9, 2014
Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

News
Ranbaxy image

Ranbaxy and Sun Pharma merger approved

December 9, 2014
Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, cci, tamsulosin, tolterodine

The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …

News

Pfizer buys into gene therapy

December 9, 2014
Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …

News
bio_wim_sep_2014

Celgene appoints new UK general manager

December 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Wim Souverijns

Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …

Appointment
Novartis image

AZ triumphs in Nexium pay-for-delay trial

December 8, 2014
Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole

AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …

News
Merck image

Updated: Merck buys antibiotics specialist Cubist

December 8, 2014
Sales and Marketing Antibiotics, Merck, Novartis, cubicin, cubist, eumer

Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …

News

Blackberry creates cancer diagnostic tool

December 8, 2014
Medical Communications, Sales and Marketing Blackberry, chen, diagnostic, nanthealth, passport, soon-shiong

Canadian smartphone maker Blackberry is entering the healthcare arena with a cancer diagnostic tool aimed at doctors and nurses. Via …

News
Galderma image

Merck and Galderma breach ABPI code

December 8, 2014
Medical Communications, Sales and Marketing ABPI, Erbitux, Galderma, PMCPA, merch

Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …

News
Actos image

Analysis finds no Actos bladder cancer link

December 8, 2014
Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …

News
People image

The valuable world of Real World Evidence

December 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …

Feature
james_christie_abpi

ABPI appoints first manufacturing director

December 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie

The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …

Appointment
Bayer image

Bayer files haemophilia drug in EU

December 5, 2014
Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate

Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …

News
GSK image

GSK cancels sale of established products

December 5, 2014
Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026